Head-to-head · WeighScore
Found vs GoodRx
By GLP-1 ScorecardUpdated
Score comparison
Found has the higher recorded score — 83.5/100 to 69.6/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Found | GoodRx |
|---|---|---|
| WeighScore | 83.5/100 | 69.6/100 |
| Grade | B | C |
| Site position | #8 | #132 |
| Semaglutide | $179 first, then $289 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Wegovy pill from $149 at 1.5 mg; injection $199 for two qualifying fills then $349. Separate $39/mo care fee if subscribed; dose/offer conditions apply. |
| Tirzepatide | $219 first, then $359 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) | Zepbound KwikPen advertised from $299; dose-specific and 28-day supply/refill conditions apply. Separate $39/mo care fee if subscribed; confirm pharmacy quote. |
| Coverage | U.S. service with state, treatment and insurance restrictions; confirm your eligibility | Prescription savings at participating U.S. pharmacies; Care Direct weight-loss prescribing excludes Alabama and Louisiana. Confirm the specific treatment and pharmacy. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #8 · B
Strengths
- Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
- Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
- Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
- Terms name possible independent medical groups and describe check-ins and messaging
What to consider
- Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
- Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
- Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
- Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
- The assigned compounder, actual treating practice and individual license status remain unresolved
- A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Site position #132 · C
Strengths
- Free prescription discounts can be used without purchasing the weight-loss care subscription
- Current Care Direct menu names oral Wegovy, injectable Wegovy/HD, Foundayo tablets and Zepbound KwikPen
- Publishes a separate $39 monthly care fee rather than presenting it as the medication price
- Official terms name possible medical groups and dispensing pharmacies; the guide explains pharmacy selection
What to consider
- Medication is extra; dose offers do not establish continuing cost. Foundayo and Zepbound self-pay card savings end December 31, 2026
- The Zepbound page has an inconsistent 10 mg lowest-dose label; confirm device, strength and selected quote
- Support and terms differ on the initial care-charge trigger; renewals are automatic and cancellation requires at least one day’s notice
- Care Direct weight-loss treatment excludes Alabama and Louisiana, and the guide says no insurance prior-authorization submissions
- Actual dispensing branch, lab costs and refill timing still require confirmation; canceling does not guarantee a refund
Featured provider
Found
Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.